Effect of adriamycin and hyperthermia on the sedimentation of nucleoids from L1210 cells.
We report on the individual and combined effects of adriamycin (ADR) and hyperthermia (HYP) on the sedimentation behavior of L1210 mouse leukemia cell nucleoids in neutral sucrose gradients. Nucleoid sedimentation profiles obtained from cells incubated with ADR (1-10 microM; 30 min; 37 degrees C) exhibited an increased sedimentation rate associated with an increased protein content of these subnuclear units. Exposure of cells to HYP (1-3 h; 42 degrees C) produced similar results. Simultaneous exposure of L1210 cells to conditions of HYP and ADR which resulted in minimal changes in nucleoid sedimentation when used singly, produced an enhanced effect. A similar enhancement was observed with other intercalating antineoplastic agents believed to exert their effect, at least partially, via free radicals (daunorubicin, amsacrine, bisantrene, mitoxantrone). However, enhancement with HYP was not observed with (a) the classic intercalating agent, ethidium bromide; (b) non-intercalating DNA-breaking agents (bleomycin, lithocholic acid, etoposide); (c) inhibitors of poly (ADP-ribose) polymerase (m-methoxybenzamide, benzamide); or (d) non-intercalating antineoplastic agents capable of causing free radical formation (bleomycin). The results suggest that DNA intercalating agents capable of initiating free radical processes may show an enhanced toxicity with simultaneous HYP treatment, and that the nucleoid assay may be a means of screening agents with these biological properties for potential clinical usefulness in combination with HYP.
Daugherty
J P
JP
Comprehensive Cancer Center, University of Alabama, Birmingham 35294.
Simpson
T A
TA
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002499:Centrifugation, Density Gradient; D004273:DNA, Neoplasm / Q000032:analysis; D004278:DNA, Superhelical / Q000032:analysis; D004317:Doxorubicin / Q000494:pharmacology*; D006358:Hot Temperature; D007939:Leukemia L1210 / Q000235:genetics / Q000473:pathology*; D051379:Mice; D009363:Neoplasm Proteins / Q000032:analysis; D013347:Subcellular Fractions / Q000032:analysis
D004273:DNA, Neoplasm; D004278:DNA, Superhelical; D009363:Neoplasm Proteins; D004317:Doxorubicin